Jinyi Li

ORCID: 0000-0002-3627-3815 · 1 paper in corpus · active 2020

Study types

  • article 1

Condition tags

  • endometriosis 1
article 2020
Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women
Clinical pharmacology in drug development ·doi:10.1002/cpdd.851

Abstract Vilaprisan is a novel selective progesterone receptor modulator for the long‐term treatment of uterine fibroids and endometriosis. This study investigated the pharmacokinetics, safety, and tolerability of vilaprisan in healthy Chin…